DHG Pharmaceutical JSC (HOSE:DHG)

DHG Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	149,987	62,858	94,134	34,018	43,374	73,054
Short-Term Investments	2,575,000	2,485,000	1,960,000	2,265,000	1,975,000	1,974,000
Cash & Short-Term Investments	2,724,987	2,547,858	2,054,134	2,299,018	2,018,374	2,047,054
Cash Growth	-0.10%	24.04%	-10.65%	13.90%	-1.40%	20.53%
Accounts Receivable	476,591	523,860	528,859	279,862	315,113	363,249
Other Receivables	56,102	86,838	96,075	81,417	77,757	63,328
Receivables	532,950	610,955	625,192	361,537	393,141	426,958
Inventory	1,094,136	1,115,429	1,534,636	1,250,834	1,072,606	826,585
Prepaid Expenses	6,473	8,653	8,007	10,201	5,827	3,327
Other Current Assets	41,005	321,109	420,224	297,183	237,346	176,875
Total Current Assets	4,399,551	4,604,004	4,642,193	4,218,772	3,727,293	3,480,800
Property, Plant & Equipment	1,070,823	1,066,375	1,187,884	678,171	631,658	705,687
Long-Term Investments	4,560	4,438	4,175	3,860	4,578	4,388
Other Intangible Assets	177,167	178,106	181,861	201,812	205,780	210,084
Long-Term Deferred Tax Assets	18,340	18,340	16,872	15,845	17,535	16,068
Other Long-Term Assets	85,067	87,982	77,489	49,726	30,822	30,477
Total Assets	5,755,508	5,959,243	6,110,474	5,168,187	4,617,666	4,447,503
Accounts Payable	328,791	167,297	217,976	364,379	201,220	252,271
Accrued Expenses	197,633	339,445	313,579	227,615	257,956	255,737
Short-Term Debt	688,705	649,914	572,165	114,723	207,391	212,272
Current Income Taxes Payable	35,095	22,417	17,365	12,678	4,208	14,624
Current Unearned Revenue	28,557	48,507	43,702	34,043	49,609	49,532
Other Current Liabilities	41,828	562,713	24,454	58,098	37,332	31,999
Total Current Liabilities	1,320,608	1,790,293	1,189,242	811,537	757,716	816,433
Other Long-Term Liabilities	73,906	74,195	68,298	65,113	66,807	63,031
Total Liabilities	1,394,513	1,864,488	1,257,540	876,650	824,523	879,464
Common Stock	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461	1,307,461
Additional Paid-In Capital	6,779	6,779	6,779	6,779	6,779	6,779
Retained Earnings	3,046,755	2,780,515	3,538,695	2,977,297	2,475,770	2,249,731
Total Common Equity	4,360,995	4,094,755	4,852,935	4,291,537	3,790,010	3,563,971
Minority Interest	-	-	-	-	3,134	4,068
Shareholders' Equity	4,360,995	4,094,755	4,852,935	4,291,537	3,793,144	3,568,039
Total Liabilities & Equity	5,755,508	5,959,243	6,110,474	5,168,187	4,617,666	4,447,503
Total Debt	688,705	649,914	572,165	114,723	207,391	212,272
Net Cash (Debt)	2,036,282	1,897,944	1,481,969	2,184,294	1,810,982	1,834,783
Net Cash Growth	-6.72%	28.07%	-32.15%	20.61%	-1.30%	27.98%
Net Cash Per Share	15574.33	14516.26	11334.72	16706.39	13851.14	14033.18
Filing Date Shares Outstanding	130.75	130.75	130.75	130.75	130.75	130.75
Total Common Shares Outstanding	130.75	130.75	130.75	130.75	130.75	130.75
Working Capital	3,078,943	2,813,711	3,452,951	3,407,236	2,969,577	2,664,367
Book Value Per Share	33354.69	31318.38	37117.25	32823.45	28987.56	27258.72
Tangible Book Value	4,183,828	3,916,649	4,671,074	4,089,725	3,584,230	3,353,886
Tangible Book Value Per Share	31999.64	29956.15	35726.31	31279.91	27413.67	25651.91
Buildings	776,502	776,502	575,489	578,613	528,464	528,464
Machinery	1,409,189	1,374,826	1,029,566	903,189	866,975	875,218
Construction In Progress	47,277	48,614	553,594	92,596	69,508	66,473

Source: S&P Global Market Intelligence. Standard template. Financial Sources.